Oxford Cancer is a city-wide network and partnership between Oxford University and Oxford University Hospitals NHS Trust, established with funding from Cancer Research UK in recognition of the University's breakthrough research in cancer. Oxford Cancer coordinates collaboration across the city of Oxford to ensure rapid translation from scientific discovery to treatments for patients.
The Oxford Cancer Oversight Committee facilitates efforts across the University, comprising over 900 members from around 90 different Departments, Units, Institutes of the University, as well as the NHS Trust who invest over £55m each year into translational cancer research. Meeting twice a year, The Committee will advise and help in reaching the strategic objectives of the centre.
On his invitation to join The Committee, Professor Pawel Swietach said: "I am delighted to be a member of this committee. I am keen to highlight DPAG’s interests in the extensive network of cancer scientists at Oxford. DPAG can play an active role in new, multi-disciplinary programmes and to enable this, my priority is to look out for opportunities to pair the best scientists and state-of-the-art facilities across our city. DPAG has much potential in these endeavours as our expertise lies in systems biology. This integrative approach to understanding disease is important at a time when large volumes of data are collected, and must be assembled together into working models. I look forward to hearing from colleagues about how best to involve our department in University-wide activities."